Compound Detail
CHEMBL1807446
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1807446 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CQPNJQRTSADQCI-UHFFFAOYSA-N |
4
Targets
7
Activities
1
Assay Types
3
PK Parameters
20
Publications
0
Known Names
Molecular Properties
425.5
MW (Da)
4.21
ALogP
6
HBA
2
HBD
88.4
PSA (Ų)
0.45
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 8.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Mitogen-activated protein kinase 14 CHEMBL260 | IC50 | 8.4 | 8.4 | 4.0 | 2 |
| Mitogen-activated protein kinase 11 CHEMBL3961 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| PBMC CHEMBL613107 | IC50 | 7.68 | 7.2767 | 21.0 | 3 |
| Blood CHEMBL613408 | IC50 | 6.42 | 6.42 | 382.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 2300.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 0.08 | nmol/min/mg | Homo sapiens |
| Cmax | 1767.37 | nM | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Mitogen-activated protein kinase 14 | IC50 | = | 4.0 | nM | 8.4 | Inhibition of human cloned GST-fused p38alpha expressed in Escherichia coli usin... | 21705217 |
| Mitogen-activated protein kinase 14 | IC50 | = | 4.0 | nM | 8.4 | Inhibition of P38alpha MAPK (unknown origin) | 31445234 |
| Mitogen-activated protein kinase 11 | IC50 | = | 19.0 | nM | 7.72 | Inhibition of p38beta | 21705217 |
| PBMC | IC50 | = | 21.0 | nM | 7.68 | Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced IL... | 21705217 |
| PBMC | IC50 | = | 41.0 | nM | 7.39 | Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced IL... | 21705217 |
| PBMC | IC50 | = | 173.0 | nM | 6.76 | Antiinflammatory activity in human PBMC assessed as inhibition of LPS-induced IL... | 21705217 |
| Blood | IC50 | = | 382.0 | nM | 6.42 | Antiinflammatory activity in monkey whole blood assessed as inhibition of LPS-in... | 21705217 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Unchecked | 5 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | PBMC | 5 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Rattus norvegicus | 4 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Mus musculus | 2 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Tyrosine-protein kinase JAK3 | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Inhibitor of nuclear factor kappa-B kinase subunit beta | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Protein kinase C delta type | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Protein kinase C alpha type | 1 |
| 31445234 | 10.1016/j.ejmech.2019.111624 | Mitogen-activated protein kinase 14 | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Hepatocyte growth factor receptor | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Tyrosine-protein kinase Lck | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Mitogen-activated protein kinase 8 | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Mitogen-activated protein kinase 13 | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Insulin-like growth factor 1 receptor | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Receptor tyrosine-protein kinase erbB-2 | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Epidermal growth factor receptor | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Fibroblast growth factor receptor 1 | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Tyrosine-protein kinase ITK/TSK | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | Cyclin-dependent kinase 2 | 1 |
| 21705217 | 10.1016/j.bmcl.2011.05.091 | RAC-alpha serine/threonine-protein kinase | 1 |
Data from ChEMBL 36 via Core Engine